Privium Fund Management B.V. Pro Qr Therapeutics N.V. Transaction History
Privium Fund Management B.V.
- $551 Million
- Q3 2025
A detailed history of Privium Fund Management B.V. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Privium Fund Management B.V. holds 4,998,287 shares of PRQR stock, worth $10.9 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
4,998,287
Previous 4,997,562
0.01%
Holding current value
$10.9 Million
Previous $10.2 Million
3.44%
% of portfolio
1.92%
Previous 2.17%
Shares
8 transactions
Others Institutions Holding PRQR
# of Institutions
65Shares Held
38.3MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.25MShares$13.7 Million0.02% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.6MShares$7.88 Million0.88% of portfolio
-
Morgan Stanley New York, NY2.9MShares$6.35 Million0.0% of portfolio
-
Abrdn PLC2.3MShares$5.03 Million0.01% of portfolio
-
Sio Capital Management, LLC New York, NY2.08MShares$4.54 Million1.52% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $156M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...